Literature DB >> 14236560

EXPERIMENTAL APPROACHES TO THE DEVELOPMENT OF ANTIANGINAL DRUGS.

M M WINBURY.   

Abstract

Keywords:  ANGINA PECTORIS; CORONARY VESSELS; DRUG THERAPY; HEMODYNAMICS; NITRITES; PHARMACOLOGY; REVIEW; VASODILATOR AGENTS

Mesh:

Substances:

Year:  1964        PMID: 14236560     DOI: 10.1016/s1054-3589(08)61110-2

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 0568-0123


× No keyword cloud information.
  8 in total

1.  On the mode of action of antianginal drugs.

Authors:  L Szekeres
Journal:  Basic Res Cardiol       Date:  1978 Mar-Apr       Impact factor: 17.165

2.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

3.  [The effect of coronary dilator drugs on oxygen pressure and blood supply of the dog myocardium, normal and with coronary insufficiency].

Authors:  R Kadatz
Journal:  Arch Kreislaufforsch       Date:  1969 Mar-Apr

4.  Effects of nitroglycerin on left ventricular volumes and wall tension in patients with ischaemic heart disease.

Authors:  S J Lee; Y K Sung; A J Zaragoza
Journal:  Br Heart J       Date:  1970-11

5.  Potentiation of adenosine and the adenine nucleotides by dipyridamole.

Authors:  A Stafford
Journal:  Br J Pharmacol Chemother       Date:  1966-11

6.  The possible role of adenosine in the coronary dilator action of some pyrimidopyrimidines and pteridines.

Authors:  M W Nott
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

7.  The cardiotonic effect of the crude ethanolic extract of Nerium oleander in the isolated guinea pig hearts.

Authors:  R O Adome; J W Gachihi; B Onegi; J Tamale; S O Apio
Journal:  Afr Health Sci       Date:  2003-08       Impact factor: 0.927

8.  The effects of nitroglycerin on coronary collaterals and myocardial contractility.

Authors:  M V Cohen; J M Downey; E H Sonnenblick; E S Kirk
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.